Aptevo Therapeutics Inc (NQ: APVO )
32.71
USD
+1.09
(+3.45%)
Streaming Delayed Price
Updated: 4:00 PM EST, Feb 26, 2021
Add to My Watchlist
Press releases about Aptevo Therapeutics Inc
Aptevo Confirms Receipt of Nominations and Proposal Notice
February 09, 2021
From ACCESSWIRE
From ACCESSWIRE
Aptevo Therapeutics Announces the Launch of Its Second Platform Technology ADAPTIR-FLEX(TM) and Introduces the New Bispecific Prostate Cancer Candidate APVO442
December 02, 2020
From ACCESSWIRE
Aptevo Confirms Receipt of Unsolicited Indication of Interest
November 19, 2020
From ACCESSWIRE
Thinking about buying stock in Aptevo Therapeutics, Electrameccanica Vehicles, AstraZeneca, Corcept Therapeutics, or 22nd Century Group?
November 19, 2020
From PR Newswire
Aptevo Therapeutics and Alligator Bioscience advancing the bispecific 4-1BBx5T4 antibody ALG.APV-527 into Phase I clinical development
November 16, 2020
From PR Newswire
Aptevo Therapeutics and Alligator Bioscience Advancing the Bispecific 4-1BBx5T4 Antibody ALG.APV-527 Into Phase 1 Clinical Development
November 16, 2020
From ACCESSWIRE
Thinking about buying stock in Surface Oncology, Northern Oil & Gas, Co-Diagnostics, Howmet Aerospace, or Aptevo Therapeutics?
November 11, 2020
From PR Newswire
Aptevo Therapeutics Reports Third Quarter Financial Results and Provides Business Update
November 10, 2020
From ACCESSWIRE
Aptevo Therapeutics to Present at the Society for Immunotherapy of Cancer's (SITC) 35th Virtual Annual Meeting
November 09, 2020
From ACCESSWIRE
Tags
Featured News
From PR Newswire
Thinking about buying stock in American Airlines, Carnival Corp, Pfizer, Aptevo Therapeutics, or Aurora Cannabis?
November 09, 2020
From PR Newswire
Aptevo Therapeutics Announces Second Complete Remission in Ongoing APVO436 Phase 1 Clinical Trial
November 09, 2020
From ACCESSWIRE
Aptevo Therapeutics Adopts Limited Duration Stockholder Rights Plan
November 08, 2020
From ACCESSWIRE
Thinking about buying stock in Sundial Growers, Aptevo Therapeutics, Aphria Inc, Medifast, or Freeport-McMoRan?
November 03, 2020
From PR Newswire
Aptevo Therapeutics Announces First Complete Remission in Ongoing APVO436 Phase 1 Clinical Trial
November 03, 2020
From ACCESSWIRE
From ACCESSWIRE
From ACCESSWIRE
Aptevo Therapeutics Secures $25 Million Non-Dilutive Financing from Midcap Financial Trust
August 06, 2020
From ACCESSWIRE
Aptevo Therapeutics Engages Piper Sandler to Sell its RUXIENCE(R) and IXINITY(R) Royalty Streams & Milestones
July 21, 2020
From ACCESSWIRE
Aptevo Therapeutics Collects $750,000 Working Capital Escrow From Medexus Related to IXINITY(R) Sale
June 29, 2020
From ACCESSWIRE
Thinking about buying stock in Ekso Bionics, Apple Inc, GNC Holdings, Microsoft Corp, or Aptevo Therapeutics?
June 25, 2020
From PR Newswire
Aptevo Therapeutics to receive Seven Year Quarterly Royalty Payment Stream from Pfizer for Sales of Rituximab Biosimilar
June 25, 2020
From ACCESSWIRE
From PR Newswire
From ACCESSWIRE
From ACCESSWIRE
From ACCESSWIRE
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.